| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 09/21/1999 | US5955585 Catalytic condensation method for the preparation of chlorophyll and bacteriochlorophyll derivatives |
| 09/21/1999 | US5955576 Peptide aldehyde analogs that inhibit thrombin or factor xa; for prevention or treatment of abnormal thrombosis |
| 09/21/1999 | US5955571 Novel n-branched nucleic acids with non-ribose phosphate backbone; for use in controlling gene expression, antisense agents, viricides, diagnosis, and genetic engineering techniques |
| 09/21/1999 | US5955503 Modified amino acid compounds useful as carriers in the delivery of biologically active agents such as, for example, bioactive peptides and the like |
| 09/21/1999 | US5955491 Method for treating osteoporosis |
| 09/21/1999 | US5955434 N-terminal fmoc-protected peptide combinations that form gels in water |
| 09/21/1999 | US5955433 Method of thrombin inhibition |
| 09/21/1999 | US5955432 Stimulants for hematopoiesis, protection of cells from radiation |
| 09/21/1999 | US5955431 Mast cell protease peptide inhibitors |
| 09/21/1999 | US5955421 Peptides containing D-2-alkyl-Tryptophan |
| 09/16/1999 | WO1999046575A2 Peptides containing a cholesterol recognition sequence and their uses |
| 09/16/1999 | WO1999046283A1 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 09/16/1999 | WO1999045945A1 Improved radiation therapy methods |
| 09/16/1999 | WO1999045941A1 Peptide compositions and formulations and use of same |
| 09/16/1999 | WO1999045928A1 IgE ANTIBODY PRODUCTION INHIBITORS AND AUTOIMMUNE DISEASES INHIBITORS |
| 09/16/1999 | CA2659664A1 Improved radiation therapy methods |
| 09/16/1999 | CA2327329A1 Cholesterol recognition sequence |
| 09/16/1999 | CA2323443A1 Ige antibody production inhibitors and autoimmune diseases inhibitors |
| 09/16/1999 | CA2322839A1 Peptide compositions and formulations and use of same |
| 09/16/1999 | CA2321026A1 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 09/15/1999 | EP0941232A1 Ligands for phosphatase binding assay |
| 09/15/1999 | EP0941218A1 Antithrombotic organic nitrates |
| 09/15/1999 | EP0941120A1 Branched peptide linkers |
| 09/15/1999 | EP0941104A1 Peptide synthesis with sulfonyl protecting groups |
| 09/15/1999 | CN1228783A Thrombin inhibitor |
| 09/15/1999 | CN1228769A Process for preparing amidines |
| 09/14/1999 | US5952499 Therapeutic compound-fatty acid conjugates |
| 09/14/1999 | US5952492 Reacting a mixture of diacid with dimethyl pimelate, hydrochloric acid, methanol, dibutyl ether to form intermediate, adding o-benzyl hydroxylamine hydrochloride and triethylamine, additing di-tert-butyl dicarbonate |
| 09/14/1999 | US5952343 HIV protease inhibitors |
| 09/14/1999 | US5952327 Neutral endopeptidase inhibitors; treatment of cardiovascular disorders |
| 09/14/1999 | US5952307 Antiinflammatory agents, anticoagulants, antitumor agents |
| 09/14/1999 | US5952306 Integrin receptor antagonists |
| 09/14/1999 | US5952294 Peptidyl prodrugs and methods of making and using the same |
| 09/14/1999 | CA2086924C Method for the preparation of sulphinyl pristinamycin iib |
| 09/10/1999 | WO1999045029A1 New salt forms of (2e)- 5-amino-5- methylhex-2- enoic acid n-methyl-n-((1r)-1-(n- methyl-n-((1r)-1-(methylcarbamoyl)-2- phenylethyl)carbamoyl)-2- (2-naphtyl)ethyl)amide |
| 09/10/1999 | WO1999045027A1 Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymes |
| 09/10/1999 | WO1999045020A1 Isolation of tissue specific peptide ligands and their use for targeting pharmaceuticals to organs |
| 09/10/1999 | WO1999045000A1 Process for producing 4-thiazolylmethyl derivative |
| 09/10/1999 | WO1999044628A1 Conjugates useful in the treatment of prostate cancer |
| 09/10/1999 | WO1999032428A3 Synthesis of diamines |
| 09/10/1999 | CA2322838A1 Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymes |
| 09/10/1999 | CA2322051A1 New salt forms of (2e)- 5-amino-5- methylhex-2- enoic acid n-methyl-n-((1r)-1-(n- methyl-n-((1r)-1-(methylcarbamoyl)-2- phenylethyl)carbamoyl)-2- (2-naphthyl)ethyl)amide |
| 09/10/1999 | CA2321171A1 Conjugates useful in the treatment of prostate cancer |
| 09/08/1999 | EP0940400A1 Novel heterocyclic amide compounds and medicinal uses thereof |
| 09/08/1999 | EP0939765A1 Glycoconjugates of modified camptothecin derivatives (a- or b-ring linkage) |
| 09/08/1999 | EP0939758A1 HETEROCYCLIC DERIVATIVES AS FACTOR Xa INHIBITORS |
| 09/08/1999 | EP0939643A1 Immunomodulating compounds comprising d-isomers of amino acids |
| 09/07/1999 | US5948939 An omega-guanidino-alpha-amino-acid (or its functional derivative) may be prepared by the reaction of the omega-amino group of an alpha,omega-diamino acid (or its functional derivative) or a compound containing it with a |
| 09/07/1999 | US5948889 Purified bacterial cell division protein for screening libraries of compounds |
| 09/07/1999 | US5948886 Acylated enol derivatives of α-ketoesters and α-ketoamides |
| 09/07/1999 | US5948790 Retroviral protease inhibitors |
| 09/07/1999 | US5948778 Difluoro statone antiviral analogs |
| 09/07/1999 | US5948763 Inhibitory peptide having a length of three to fifteen amino acids and comprising a portion of three to eight amino acids, which portion is hydrophobic and has one or more .beta.-sheet blocking amino acid residues therein |
| 09/07/1999 | CA1340726C Redox amino acids and peptides containing them |
| 09/02/1999 | WO1999043337A1 Cyclic peptide antifungal agents |
| 09/02/1999 | WO1999024460A3 Dipeptide nitriles |
| 09/02/1999 | CA2321928A1 Cyclic peptide antifungal agents |
| 09/01/1999 | EP0939121A2 TNF-binding proteins |
| 09/01/1999 | EP0938498A1 Multivalent compounds for cross-linking receptors and uses thereof |
| 09/01/1999 | EP0938494A1 Inhibitors of protein farnesyl transferase |
| 09/01/1999 | EP0938326A1 Synthetic phosphopeptides for treating bone diseases |
| 08/31/1999 | US5945408 Hydroxyanidino derivatives useful as nitric oxide synthase inhibitors |
| 08/31/1999 | CA2183315C Novel mercaptoacetylamido 1,3,4,5-tetrahydro-benzo[c]azepin-3-one disulfide derivatives useful as inhibitors of enkephalinase and ace |
| 08/31/1999 | CA2183314C Novel 2-substituted indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace |
| 08/31/1999 | CA2173328C Hiv protease inhibitors |
| 08/26/1999 | WO1999042648A1 Method for cleaning solid materials and apparatus for applying this method |
| 08/26/1999 | WO1999042475A1 Azole peptidomimetics as thrombin receptor antagonists |
| 08/26/1999 | WO1999042429A1 Antitumor agents |
| 08/26/1999 | WO1999042116A1 Novel disulfides and thiol compounds |
| 08/26/1999 | WO1999042099A1 Low molecular weight compounds administered together with anti-cancer agents to treat cancer and pharmaceutical compositions thereof |
| 08/26/1999 | WO1999042098A1 Small molecules that increase the conversion of food to body weight gain |
| 08/26/1999 | WO1999042097A1 Small molecules that elicit a polarized th1 response and for modulation of cellular immunity |
| 08/26/1999 | CA2321961A1 Novel disulfides and thiol compounds |
| 08/26/1999 | CA2321814A1 Small molecules that increase the conversion of food to body weight gain |
| 08/26/1999 | CA2321104A1 Azole peptidomimetics as thrombin receptor antagonists |
| 08/25/1999 | EP0937157A1 Hydrolase binding assay |
| 08/25/1999 | EP0937073A2 Selective factor xa inhibitors |
| 08/25/1999 | EP0937042A1 Heteroaryl succinamides and their use as metalloproteinase inhibitors |
| 08/25/1999 | EP0755405B1 Phosphonyldipeptides useful in the treatment of cardiovascular diseases |
| 08/25/1999 | CN1226897A Isolated peptides derived from mage-2 |
| 08/25/1999 | CN1226895A Amino acid derivatives and their use as thrombin inhibitors |
| 08/24/1999 | US5942620 Methods for producing novel conjugates of thrombin inhibitors |
| 08/24/1999 | US5942600 Compounds with selective control of fungal organism candida albicans for treatment in humans, for example those with weakened immune systems due to aids; species-specific control |
| 08/24/1999 | CA2166693C Difluoro statone analogs |
| 08/19/1999 | WO1999041367A1 Heteroaromatic oligoamides as affinity ligands |
| 08/19/1999 | WO1999041277A1 Novel acetamide derivative and use thereof |
| 08/19/1999 | WO1999041276A1 β-SHEET MIMETICS AND METHODS RELATING TO THE USE THEREOF |
| 08/19/1999 | WO1999041275A1 Prodrugs |
| 08/19/1999 | WO1999041268A1 Nucleosides |
| 08/19/1999 | WO1999040931A1 Cyclic dipeptides and azetidinone compounds and their use in treating cns injury and neurodegenerative disorders |
| 08/19/1999 | WO1999040930A1 Specific inhibitors of nfat activation by calcineurin and their use in treating immune-related diseases |
| 08/19/1999 | WO1999031121A3 Branched building units for synthesizing cyclic peptides |
| 08/19/1999 | CA2321146A1 Novel acetamide derivative and use thereof |
| 08/19/1999 | CA2320378A1 Cyclic dipeptides and azetidinone compounds and their use in treating cns injury and neurodegenerative disorders |
| 08/19/1999 | CA2319766A1 .beta.-sheet mimetics and methods relating to the use thereof |
| 08/19/1999 | CA2318978A1 Prodrugs |
| 08/19/1999 | CA2318975A1 Prodrugs of 2'3'-dideoxy-3'-fluoro guanosine |
| 08/18/1999 | EP0935611A1 Serine protease inhibitors |
| 08/18/1999 | EP0935608A1 Cytotoxic peptides |
| 08/18/1999 | EP0935467A1 Compounds that inhibit interaction between signal-transducing proteins and the glgf (pdz/dhr) domain and uses thereof |